India is strengthening its mental healthcare system with a renewed policy focus on access, equity, and early intervention. The expansion of national institutions like NIMHANS, the rollout of tele-mental health services such as Tele-MANAS, and integration of mental health into primary healthcare reflect a shift toward treating mental health as a core public health priority. These efforts aim to reduce the large treatment gap, address regional disparities, tackle stigma, and build a stronger mental health workforce, especially for vulnerable and underserved populations.
Click to View MoreThe Jal Jeevan Mission has rapidly expanded tap water infrastructure in rural
India, achieving near-universal coverage of household connections. However,
recent assessments show that actual water supply, reliability, and quality lag
behind coverage figures, with many households not receiving regular or safe
water. Issues such as groundwater depletion, weak operation and
maintenance, and water contamination remain key challenges. The focus now
needs to shift from infrastructure creation to ensuring sustainable, reliable, and
community-managed rural drinking water services.
India’s public health spending remains persistently low, with total government expenditure hovering around 1.5–2% of GDP, far below the 2.5% target set by the National Health Policy. While States have gradually increased their health allocations, the Union government’s share as a percentage of GDP has declined after a temporary rise during COVID-19. This underinvestment leads to overburdened public hospitals, weak primary healthcare, high out-of-pocket expenses, and regional inequalities. Despite major initiatives like Ayushman Bharat and the National Health Mission, inadequate and inconsistent funding continues to limit progress toward universal, affordable, and equitable healthcare in India.
Click to View MoreAntimicrobial resistance (AMR) is being driven largely by the excessive and inappropriate use of antibiotics. A significant proportion of patients receive antibiotics without confirmed infections, with most prescriptions given empirically rather than based on laboratory diagnosis. This irrational use accelerates the development of drug-resistant microbes.
AMR now threatens the effective treatment of common infections, increases healthcare costs, and makes routine medical procedures riskier. Addressing the crisis requires stronger surveillance, better prescribing practices, improved diagnostics, public awareness, and coordinated national and global efforts under a One Health approach.
Click to View MoreIndia has made major progress toward malaria elimination under its National Framework for Malaria Elimination (2016–2030), with cases falling by around 80% between 2015 and 2023. Many districts have already reported zero indigenous cases, and the country has exited the WHO High Burden to High Impact group. The strategy now focuses on strong surveillance through the “Test, Treat and Track” approach, universal access to diagnosis and treatment, and intensified vector control.
However, challenges remain in the form of migration, urban malaria, hard-to-reach tribal and forested areas, and the persistence of Plasmodium vivax, which can relapse. Drug and insecticide resistance are also emerging concerns. India aims to achieve zero indigenous cases by 2027 and full elimination by 2030, but success will depend on accurate reporting, strong urban and community participation, and preventing re-establishment of transmission in malaria-free areas.
Click to View MoreEarly childhood care and development, especially during the first 3,000 days of life, is crucial for building strong human capital. While India has improved child survival through health and nutrition programmes, holistic development covering cognitive, emotional and social aspects remains underemphasised. Global evidence shows that early investment yields the highest economic and social returns. A universal, integrated and citizen-led ECCD approach is essential for achieving inclusive growth and the vision of Viksit Bharat.
Click to View MoreA recent scare over counterfeit rabies vaccines has raised serious public-health concerns. Suspected fake or repackaged batches of a commonly used rabies vaccine were reported in multiple Indian cities, prompting advisories from several countries for travellers vaccinated in India. Investigations indicate that while most vials contained genuine vaccine, packaging was altered and government-supplied stock was likely diverted to the private market, revealing weaknesses in supply-chain monitoring. The incident risks creating vaccine hesitancy for a disease that is almost 100% fatal once symptoms appear. The crisis underscores the need for strict regulation, better tracking systems, strong law enforcement, transparent public communication, and assured availability of authentic vaccines and immunoglobulin to maintain trust and prevent avoidable deaths.
Click to View MoreIndia is debating the introduction of data exclusivity in pharmaceuticals, a regulatory protection that can delay the entry of generic drugs even after patent expiry. While the move is projected as a way to attract investment and support innovation, it raises serious concerns for India’s generics-driven pharmaceutical industry and access to affordable medicines. In the absence of any international obligation under WTO-TRIPS, the policy choice involves balancing innovation incentives with public health priorities and preserving India’s role as the pharmacy of the developing world.
Click to View MoreIndia faces the world’s highest burden of snakebite deaths, largely due to delayed treatment and weak rural health linkages. The ICMR-led Zero Snakebite Death Initiative seeks to address this gap by integrating community-based prevention, rapid response, and evidence-driven health system strengthening, drawing on successful local models such as Assam’s Demow Model. By shifting the focus from hospital-centric care to early intervention and community empowerment, the initiative offers a realistic pathway to significantly reduce preventable snakebite mortality in India.
Click to View MoreGallbladder cancer has emerged as a silent epidemic in India’s Gangetic belt, driven by polluted water, food contamination, poverty and gender inequality. It disproportionately affects rural women, often detected late with high treatment costs and poor survival. Weak surveillance, non-notifiability of cancer and ineffective environmental governance keep the crisis invisible. Addressing it requires pollution control, gender-sensitive screening, clean water access, stronger cancer reporting systems and integrated health–environment policy action.
Click to View MoreThe Fugitive Economic Offenders Act, 2018 empowers India to act against high-value financial offenders who flee abroad by enabling courts to declare them fugitives and confiscate their properties—even in their absence. It strengthens asset recovery, deters flight risk behaviour and supports extradition efforts in major scams such as those involving Vijay Mallya and Nirav Modi. However, its effectiveness is hindered by slow extradition processes, overseas asset tracing challenges and coordination issues among agencies. With stronger global cooperation, better intelligence systems and fast-track courts, the Act can further enhance India’s fight against economic crime and reinforce financial accountability.
Click to View MoreNeurotechnology—ranging from brain-computer interfaces to neural stimulation—offers India major gains in health, innovation, and economic growth by improving treatment for neurological disorders, enabling assistive devices, and creating new tech industries. Globally, countries like the U.S., China, and Chile are advancing neurotech while shaping ethical norms and neurorights. However, its promise depends on strong regulation that safeguards mental privacy, autonomy, equity, and long-term safety. If India builds research capacity, industry linkages, and ethical oversight,
Click to View More
© 2026 iasgyan. All right reserved